• Corporate Event: Rohm and Haas Company (ROH)

      • To
      • Clearing Member Firms
      • From
      • CME Clearing
      • #
      • 09-139
      • Notice Date
      • 02 April 2009
      • Effective Date
      • 03 April 2009
    • ACTION:                                                           On October 29, 2008, Shareholders of Rohm & Haas Company (“ROH”) voted concerning the proposed merger with The Dow Chemical Company (“DOW”). The merger was approved and subsequently consummated on April 1, 2009. As a result, each existing ROH Common Share will be converted into the right to receive $78.97 net cash per share.
                                                                              This action will be coordinated with the Options Clearing Corporation.
      CATEGORY:                                                     Cash Settlement
      EQUITY SYMBOL:                                            Rohm & Haas Company (“ROH”)
      ONE CHICAGO SYMBOL:                                 ROH1C will be de-listed
      CME FUTURES SYMBOL:                                 I9 will be de-listed
      MULTIPLIER:                                                   100 (e.g., 1.00 equals $100.00)
      EFFECTIVE DATE:                                           Friday, April 3, 2009
      NEW DELIVERABLE PER CONTRACT:             $7,897.00 ($78.97 x 100)
      APPLICABLE CONTRACT MONTHS:                 April, May, June, and September 2009
      SETTLEMENT PRICES AND POSITIONS:         The maturity date for all ROH1C Security Futures will be accelerated to April 3, 2009.
      NOTES:                                                            The forecasted effect of the upcoming corporate event on each clearing firms’ positions can be viewed in infopac in the Corporate Event Initial Forecast Report (ONE712), the Corporate Event Final Forecast Report (ONE713), and the Corporate Event Forecast Audit Report (CPDBU710).
                                                                              If you have any questions regarding the information provided in the document, please call CME Clearing risk management hotline at (312) 648-3888.